Washington’s life science industry in the national spotlight

Washington remains a top life science cluster with exciting and innovative news from companies across the state. Whether it’s a record-breaking deal with Pfizer acquiring Seagen or a local UW spinout raising new funding, the state continues to solidify its place in the life science industry.

After Pfizer’s acquisition, Washington is home to the largest biotech deal since 2019. The state also welcomes biotech giant Moderna with a new office focused on AI, cloud-based tools, and other technology applications opening in Seattle.

For more exciting news, subscribe to our newsletter »